US Supreme Court Justices Grill Matrixx in Case Over Shareholder Disclosure

Drug Industry Daily
A A
Zicam maker Matrixx Initiatives’ argument that adverse events do not have to be reported to a company’s shareholders until reports become statistically significant drew criticism from several U.S. Supreme Court justices Monday.

To View This Article:

Login

Subscribe To Drug Industry Daily